Kenvue company profile

KVUE · NYSE · USD

Compare Kenvue
$19.31Change from previous close: −1.28%Absolute change: −$0.25

Close · October 30, 2026

Company profile

Kenvue has 21,780 employees and is headquartered in Summit, United States.

Consumers in the United States, the rest of North America, Europe, the Middle East, Africa, Asia-Pacific and Latin America are the markets served by Kenvue, a consumer health company. Its three segments are Self Care, Skin Health and Beauty, and Essential Health, covering over-the-counter medicines, skin and hair care, sun products, oral and baby care, women's health, wound care, tampons, cosmetics and vitamins. Brands in the portfolio include Tylenol, Neutrogena, Johnson's, Listerine, Zyrtec and BAND-AID.

In the fiscal year ended December 2025, revenue reached 15.1 billion dollars, down 2.1% from the previous year, and net income was 1.5 billion dollars. North America accounted for 48.0% of revenue, with the United States alone at 42.7% and Latin America at 9.1%. Formerly known as JNTL, Inc., the company was incorporated in 2022 and employs 21,780 people, with headquarters in Summit, New Jersey.

Company facts

Sector
Consumer
Industry
Household & Personal Products
Headquarters
1 Kenvue Way, 07901, Summit
Employees
21,780
Chief executive
Kirk Perry
Founded
2022
Fiscal year
January - December
Listing
KVUE · NYSE
Currency
USD
ISIN
US49177J1025
Website
kenvue.com

Kenvue and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
KenvueKVUEUnited States$37.11B21,78019.2%21.9
Estée Lauder CompaniesELUnited States$39.35B37,95011.9%108.6
Church And DwightCHDUnited States$27.08B5,55018.6%35.2
Kimberly-ClarkKMBUnited States$68.33B36,00017.3%21.2
Colgate-PalmoliveCLUnited States$79.18B33,60020.7%38.8
CloroxCLXUnited States$12.93B9,20014.3%19.2

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Kenvue with its competitors